5435 news items
Page 4 of 100
op6v0grk6iw0k1 mflzcjekwkjx1dococu0baeb9nhzx8in4ozv4xdz
LOW
31 May 24
-K and as may be updated from time to time in Item 1A in our quarterly reports on Form 10-Q or other subsequent filings with the SEC. All such forward
tuyh6sujphrg xk2j8y5ep7sv4ay5vqyfiuytks
ASTR
31 May 24
indicating that, because Astra did not timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange
f9newbem2wlr320y ld8yb8vqypmxx
CLDT
31 May 24
of Financial Condition and Results of Operations" (or similar captions) in our quarterly reports on Form 10-Q, and as described in our other filings
ijotie cw843
JNJ
31 May 24
Factors," in Johnson & Johnson's most recently filed Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, filed with the SEC
nwjtknctmoa9la67rgf
RGF
31 May 24
of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Quarterly Report") with the Securities and Exchange Commission.
2jvtklyptmscum1xm7zmz knb0uzgdfg4b
RGF
31 May 24
satisfies Nasdaq Listing Rule 5250(c)(1) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended
dtimv1le2keaz176xat4patjwyesbz5rs3xxwsg69hspkbn8i8wn9pe0rutg
MULN
31 May 24
be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Mullen with the Securities
f4auqx5qhjjynhma4w9xgk zz255tghuqu8vtgo
MIRM
31 May 24
10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned "Risk Factors
rq75fsm
CTRN
31 May 24
are discussed in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q, respectively, and any amendments thereto, filed with the SEC
2v99p052 h1lqf6rcxt
AIM
31 May 24
-K, and any risk factors or cautionary statements included in any subsequent Form 10-Q or Form 8-K, filed with the U.S. Securities and Exchange
p20h1i5t6bhygx
LRHC
31 May 24
reports and documents that we file from time to time with the SEC, including our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31
69f80lh4mai0y1tob12u3qx06
SAIC
31 May 24
on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website
ti9tw7otqa031mr4ynyb5ozw49hb8gzep0s
GILD
31 May 24
. These and other risks, uncertainties and other factors are described in detail in Gilead's Quarterly Report on Form 10-Q for the quarter ended March 31
p729v19ch1efpwywoyg
PFE
31 May 24
on Form 10-Q, including in the sections thereof captioned "Risk Factors" and "Forward-Looking Information and Factors That May Affect Future Results
rim37xu4zyzbbj 33phmvo7f2dhkuj1lpjob1p0
ADAP
ASAN
AZ
31 May 24
due to delayed Form 10-Q.
Kintara Therapeutics, Inc
etfbq
SNGX
31 May 24
"), including, but not limited to, Soligenix's reports on Forms 10-Q and 10-K. Unless required by law, Soligenix assumes no obligation to update
6bearyp
ARWR
31 May 24
Quarterly Reports on Form 10-Q and other documents filed with the Securities and Exchange Commission from time to time. We assume no obligation to update
3k3s8
IONS
31 May 24
on Form 10-K for the year ended December 31, 2023, and most recent Form 10-Q, which
nltkvvzr kc8cv0t883mwib57yp
PNM
31 May 24
of risk factors and other important factors affecting forward-looking statements, please see the Company's Form 10-K, Form 10-Q filings
0zyi91g97lh9lsd9a1 fa2dbv4u4w11xf1zklfbccf
HTOO
31 May 24
Milestones and PrioritiesManagement Q&A Join the Webcast